AU5059093A - Simultaneous determination of HbA1c and haemoglobin variants with a glycation analogus to HbA1c - Google Patents

Simultaneous determination of HbA1c and haemoglobin variants with a glycation analogus to HbA1c

Info

Publication number
AU5059093A
AU5059093A AU50590/93A AU5059093A AU5059093A AU 5059093 A AU5059093 A AU 5059093A AU 50590/93 A AU50590/93 A AU 50590/93A AU 5059093 A AU5059093 A AU 5059093A AU 5059093 A AU5059093 A AU 5059093A
Authority
AU
Australia
Prior art keywords
hba1c
analogus
glycation
simultaneous determination
haemoglobin variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU50590/93A
Other versions
AU661207B2 (en
Inventor
Wolf-Dieter Engel
Andreas Finke
Johann Karl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4310500A external-priority patent/DE4310500A1/en
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU5059093A publication Critical patent/AU5059093A/en
Application granted granted Critical
Publication of AU661207B2 publication Critical patent/AU661207B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to a method for the immunological determination of the content of glycosylated haemoglobin in a blood sample, in which an antibody which recognises HbA1c, HbS1c and HbC1c is used, to the antibody used in this method, and to a method for producing an antibody of this type.
AU50590/93A 1992-11-17 1993-11-10 Simultaneous determination of HbA1c and haemoglobin variants with a glycation analogus to HbA1c Ceased AU661207B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4238705 1992-11-17
DE4238705 1992-11-17
DE4310500A DE4310500A1 (en) 1992-11-17 1993-03-31 Simultaneous determination of HbA1¶c¶ and hemoglobin variants with HbA1¶c¶-analogous glycation
DE4310500 1993-03-31

Publications (2)

Publication Number Publication Date
AU5059093A true AU5059093A (en) 1994-06-16
AU661207B2 AU661207B2 (en) 1995-07-13

Family

ID=25920507

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50590/93A Ceased AU661207B2 (en) 1992-11-17 1993-11-10 Simultaneous determination of HbA1c and haemoglobin variants with a glycation analogus to HbA1c

Country Status (14)

Country Link
EP (1) EP0598329B1 (en)
JP (1) JPH06225790A (en)
CN (1) CN1094061A (en)
AT (1) ATE213069T1 (en)
AU (1) AU661207B2 (en)
CA (1) CA2103318A1 (en)
CZ (1) CZ244493A3 (en)
ES (1) ES2172511T3 (en)
FI (1) FI935078A (en)
HU (1) HUT67126A (en)
IL (1) IL107622A0 (en)
NO (1) NO934139L (en)
NZ (1) NZ250198A (en)
PL (1) PL301068A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455047B1 (en) 1997-09-19 2002-09-24 Serex, Inc. Methods to improve immunogenicity of antigens and specificity of antibodies
WO2000070350A1 (en) * 1999-05-12 2000-11-23 Cme Telemetrix Inc. METHOD AND APPARATUS FOR RAPID MEASUREMENT OF HbA¿1c?
JP3949854B2 (en) 1999-10-01 2007-07-25 キッコーマン株式会社 Method for measuring glycated protein
US7449339B2 (en) 1999-11-23 2008-11-11 Nir Diagnostics Inc. Spectroscopic method and apparatus for total hemoglobin measurement
US7109309B2 (en) 2000-07-14 2006-09-19 Matsushita Electric Industrial Co., Ltd. Peptide fructose and protein conjugate with the same
WO2002006519A1 (en) 2000-07-14 2002-01-24 Arkray, Inc. Method of selectively determining glycated hemoglobin
AU2003275613A1 (en) * 2002-10-23 2004-05-13 Daiichi Pure Chemicals Co., Ltd. Novel fructosyl peptide oxidase and utilization thereof
WO2013029114A1 (en) * 2011-09-01 2013-03-07 Newsouth Innovations Pty Limited Electrochemical affinity sensor
AU2012304200A1 (en) * 2011-09-01 2013-05-02 Newsouth Innovations Pty Limited Electrochemical competition sensor
US20200283741A1 (en) * 2017-08-31 2020-09-10 Kikkoman Corporation Glycated hemoglobin oxidase variant and method for measurement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478744A (en) * 1982-01-25 1984-10-23 Sherwood Medical Company Method of obtaining antibodies
CA1339952C (en) * 1984-10-29 1998-07-14 William J. Knowles Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto
DE3439610A1 (en) * 1984-10-30 1986-04-30 Boehringer Mannheim Gmbh, 6800 Mannheim Immunogens, process for their preparation and antibodies against glycosylated haemoglobin obtained therewith
DK145385D0 (en) * 1985-03-29 1985-04-01 Novo Industri As MONOCLONAL ANTIBODY FOR IMMUNKEMIC ANALYSIS
DE3806198A1 (en) * 1988-02-04 1989-08-17 Boehringer Mannheim Gmbh IMMUNOGENS AND ITS USE TO OBTAIN ANTIBODIES AGAINST HBA (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) C (DOWN ARROW)

Also Published As

Publication number Publication date
IL107622A0 (en) 1994-02-27
HUT67126A (en) 1995-02-28
HU9303256D0 (en) 1994-03-28
JPH06225790A (en) 1994-08-16
ES2172511T3 (en) 2002-10-01
FI935078A (en) 1994-05-18
CZ244493A3 (en) 1994-05-18
EP0598329A2 (en) 1994-05-25
PL301068A1 (en) 1994-05-30
NO934139D0 (en) 1993-11-16
FI935078A0 (en) 1993-11-16
EP0598329A3 (en) 1995-06-14
ATE213069T1 (en) 2002-02-15
CN1094061A (en) 1994-10-26
AU661207B2 (en) 1995-07-13
CA2103318A1 (en) 1994-05-18
NO934139L (en) 1994-05-18
NZ250198A (en) 1994-12-22
EP0598329B1 (en) 2002-02-06

Similar Documents

Publication Publication Date Title
AU3090889A (en) Method for determination of a polyvalent substance using an immunoaggregate
AU3387193A (en) Immunological method for the determination of a haemoglobin derivative
ZA858251B (en) Immunoassays for denatured protein analytes,particularly hb alc,and monoclonal antibodies thereto
AU4926085A (en) Immunoassays for protein analytes, particularly HB A1c, involving sample denaturation
EP0864865A3 (en) Method for measuring glycated hemoglobin
AU2466588A (en) Latex agglutination immunoassay in the presence of hemoglobin
AU607088B2 (en) Process for immobilising a protein on a solid phase
AU584688B2 (en) Improvements in and relating to the determination of glycated (glycosylated) hemoglobin in blood
AU5059093A (en) Simultaneous determination of HbA1c and haemoglobin variants with a glycation analogus to HbA1c
AU640699B2 (en) Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
IL84487A (en) Immunochemical method for assaying stable glycosylated hemoglobin
AU582060B2 (en) Process for reducing turbidity in control sera
ATE205540T1 (en) METHOD FOR THE QUANTITATIVE DETERMINATION OF GLYCATED PROTEINS
CA2067584A1 (en) Agglutinant complex as blood typing reagent
EP0268296A3 (en) Membrane affinity concentration immunoassay
AU7198391A (en) Functional assay for determining the protein s activity
PL246360A1 (en) Method of determination of glucose content in proteins glycosylated non-enzymatically
RU93051178A (en) METHOD FOR SIMULTANEOUS IMMUNOLOGICAL DETERMINATION OF HB AIc AND HEMOGLOBIN OPTIONS
AU4938790A (en) Monoclonal antibodies in immune serum globulin